IRELLI, AZZURRA
IRELLI, AZZURRA
Dipartimento di Medicina clinica, sanità pubblica, scienze della vita e dell'ambiente
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer
2024-01-01 Irelli, A.; Ceriello, L.; Patruno, L. V.; Tessitore, A.; Alesse, E.; Cannita, K.; Fabiani, D.
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery
2024-01-01 Irelli, A.; Patruno, L. V.; Chiatamone Ranieri, S.; Di Giacomo, D.; Malatesta, S.; Alesse, E.; Tessitore, A.; Cannita, K.
Allostatic Load as an Insight into the Psychological Burden after Primary Treatment in Women with Breast Cancer: Influence of Physical Side Effects and Pain Perception
2022-01-01 Irelli, Azzurra; Ranieri, Jessica; Sirufo, Maria Maddalena; De Pietro, Francesca; Casalena, Pamela; Ginaldi, Lia; Cannita, Katia; Di Giacomo, Dina
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
2022-01-01 Irelli, Azzurra; Parisi, Alessandro; D'Orazio, Carla; Sidoni, Tina; Rotondaro, Silvia; Patruno, LEONARDO VALERIO; Pavese, Francesco; Bafile, Alberto; Resta, Valter; Pizzorno, Laura; Ciuffetelli, Virginia; Dal Mas, Antonella; Calvisi, Giuseppe; DI SIBIO, Alessandra; Marzullo, Anna; Zelli, Veronica; Compagnoni, Chiara; Tessitore, Alessandra; Alesse, Edoardo; Ficorella, Corrado; Cortellini, Alessio; Cannita, Katia
Invasive Ductal Breast Cancer with Osteoclast-Like Giant Cells: A Case Report Based on the Gene Expression Profile for Changes in Management
2021-01-01 Irelli, Azzurra; Sirufo, Maria Maddalena; Quaglione, Gina Rosaria; De Pietro, Francesca; Bassino, Enrica Maria; D’Ugo, Carlo; Ginaldi, Lia; De Martinis, Massimo
Denosumab in breast cancer patients receiving aromatase inhibitors: A single-center observational study of effectiveness in adjuvant setting
2021-01-01 De Martinis, Massimo; Irelli, Azzurra; Sirufo, Maria Maddalena; Scipioni, Teresa; De Pietro, Francesca; Pancotti, Amedeo; Ginaldi, Lia
Real-life use of denosumab 120 mg every 12 weeks in prolonged treatment over 2 years of patients with breast cancer bone metastases
2020-01-01 Irelli, A.; Sirufo, M. M.; D'Ugo, C.; Ginaldi, L.; de Martinis, M.
Effectiveness of restoring vitamin B12 levels in the resolution of a case of erythema nodosum
2020-01-01 Sirufo, M. M.; Ginaldi, L.; Morelli, L.; Irelli, A.; De Martinis, M.
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice
2018-01-01 Cortellini, A.; Cocciolone, V.; Irelli, A.; Pavese, F.; Sidoni, T.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Bonfili, P.; Franzese, P.; Zugaro, L.; Verna, L.; Porzio, G.; Santini, D.; Cannita, K.; Ficorella, C.
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome
2018-01-01 Cortellini, Alessio; Parisi, Alessandro; Fargnoli, Maria Concetta; Cannita, Katia; Irelli, Azzurra; Porzio, Giampiero; Martinazzo, Claudio; Ficorella, Corrado
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations.
2018-01-01 Cocciolone, Valentina; Cannita, Katia; Tessitore, Alessandra; Mastroiaco, Valentina; Rinaldi, Lucia; Paradisi, Stefania; Irelli, Azzurra; Lanfiuti Baldi, Paola; Sidoni, Tina; Ricevuto, Enrico; Dal Mas, Antonella; Calvisi, Giuseppe; Coletti, Gino; Ciccozzi, Antonietta; Pizzorno, Laura; Resta, Valter; Bafile, Alberto; Alesse, Edoardo; Ficorella, Corrado
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis.
2017-01-01 Cocciolone, V; Cannita, K; Calandrella, Ml; Ricevuto, E; Baldi, Pl; Sidoni, T; Irelli, A; Paradisi, S; Pizzorno, L; Resta, V; Bafile, A; Alesse, E; Tessitore, A; Ficorella, C
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting
2016-01-01 Cannita, Katia; Paradisi, Stefania; Cocciolone, Valentina; Bafile, Alberto; Rinaldi, Lucia; Irelli, Azzurra; Lanfiuti Baldi, Paola; Zugaro, Luigi; Manetta, Rosa; Alesse, Edoardo; Ricevuto, Enrico; Ficorella, Corrado
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel
2016-01-01 Cocciolone, Valentina; Tessitore, Alessandra; Ricevuto, Enrico; Mastroiaco, Valentina; Rinaldi, Lucia; Paradisi, Stefania; Irelli, Azzurra; Sidoni, T; Dal Mas, A; Coletti, G; Ciccozzi, A; Resta, V; Bafile, A; Alesse, Edoardo; Ficorella, Corrado; Cannita, K.
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer
2016-01-01 Irelli, Azzurra; Cocciolone, Valentina; Cannita, Katia; Zugaro, Luigi; DI STASO, Mario; Lanfiuti Baldi, Paola; Paradisi, Stefania; Sidoni, Tina; Ricevuto, Enrico; Ficorella, Corrado
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer | 1-gen-2024 | Irelli, A.; Ceriello, L.; Patruno, L. V.; Tessitore, A.; Alesse, E.; Cannita, K.; Fabiani, D. | |
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery | 1-gen-2024 | Irelli, A.; Patruno, L. V.; Chiatamone Ranieri, S.; Di Giacomo, D.; Malatesta, S.; Alesse, E.; Tessitore, A.; Cannita, K. | |
Allostatic Load as an Insight into the Psychological Burden after Primary Treatment in Women with Breast Cancer: Influence of Physical Side Effects and Pain Perception | 1-gen-2022 | Irelli, Azzurra; Ranieri, Jessica; Sirufo, Maria Maddalena; De Pietro, Francesca; Casalena, Pamela; Ginaldi, Lia; Cannita, Katia; Di Giacomo, Dina | |
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. | 1-gen-2022 | Irelli, Azzurra; Parisi, Alessandro; D'Orazio, Carla; Sidoni, Tina; Rotondaro, Silvia; Patruno, LEONARDO VALERIO; Pavese, Francesco; Bafile, Alberto; Resta, Valter; Pizzorno, Laura; Ciuffetelli, Virginia; Dal Mas, Antonella; Calvisi, Giuseppe; DI SIBIO, Alessandra; Marzullo, Anna; Zelli, Veronica; Compagnoni, Chiara; Tessitore, Alessandra; Alesse, Edoardo; Ficorella, Corrado; Cortellini, Alessio; Cannita, Katia | |
Invasive Ductal Breast Cancer with Osteoclast-Like Giant Cells: A Case Report Based on the Gene Expression Profile for Changes in Management | 1-gen-2021 | Irelli, Azzurra; Sirufo, Maria Maddalena; Quaglione, Gina Rosaria; De Pietro, Francesca; Bassino, Enrica Maria; D’Ugo, Carlo; Ginaldi, Lia; De Martinis, Massimo | |
Denosumab in breast cancer patients receiving aromatase inhibitors: A single-center observational study of effectiveness in adjuvant setting | 1-gen-2021 | De Martinis, Massimo; Irelli, Azzurra; Sirufo, Maria Maddalena; Scipioni, Teresa; De Pietro, Francesca; Pancotti, Amedeo; Ginaldi, Lia | |
Real-life use of denosumab 120 mg every 12 weeks in prolonged treatment over 2 years of patients with breast cancer bone metastases | 1-gen-2020 | Irelli, A.; Sirufo, M. M.; D'Ugo, C.; Ginaldi, L.; de Martinis, M. | |
Effectiveness of restoring vitamin B12 levels in the resolution of a case of erythema nodosum | 1-gen-2020 | Sirufo, M. M.; Ginaldi, L.; Morelli, L.; Irelli, A.; De Martinis, M. | |
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice | 1-gen-2018 | Cortellini, A.; Cocciolone, V.; Irelli, A.; Pavese, F.; Sidoni, T.; Parisi, A.; Baldi, P. L.; Venditti, O.; D'Orazio, C.; Bonfili, P.; Franzese, P.; Zugaro, L.; Verna, L.; Porzio, G.; Santini, D.; Cannita, K.; Ficorella, C. | |
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome | 1-gen-2018 | Cortellini, Alessio; Parisi, Alessandro; Fargnoli, Maria Concetta; Cannita, Katia; Irelli, Azzurra; Porzio, Giampiero; Martinazzo, Claudio; Ficorella, Corrado | |
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. | 1-gen-2018 | Cocciolone, Valentina; Cannita, Katia; Tessitore, Alessandra; Mastroiaco, Valentina; Rinaldi, Lucia; Paradisi, Stefania; Irelli, Azzurra; Lanfiuti Baldi, Paola; Sidoni, Tina; Ricevuto, Enrico; Dal Mas, Antonella; Calvisi, Giuseppe; Coletti, Gino; Ciccozzi, Antonietta; Pizzorno, Laura; Resta, Valter; Bafile, Alberto; Alesse, Edoardo; Ficorella, Corrado | |
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. | 1-gen-2017 | Cocciolone, V; Cannita, K; Calandrella, Ml; Ricevuto, E; Baldi, Pl; Sidoni, T; Irelli, A; Paradisi, S; Pizzorno, L; Resta, V; Bafile, A; Alesse, E; Tessitore, A; Ficorella, C | |
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting | 1-gen-2016 | Cannita, Katia; Paradisi, Stefania; Cocciolone, Valentina; Bafile, Alberto; Rinaldi, Lucia; Irelli, Azzurra; Lanfiuti Baldi, Paola; Zugaro, Luigi; Manetta, Rosa; Alesse, Edoardo; Ricevuto, Enrico; Ficorella, Corrado | |
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel | 1-gen-2016 | Cocciolone, Valentina; Tessitore, Alessandra; Ricevuto, Enrico; Mastroiaco, Valentina; Rinaldi, Lucia; Paradisi, Stefania; Irelli, Azzurra; Sidoni, T; Dal Mas, A; Coletti, G; Ciccozzi, A; Resta, V; Bafile, A; Alesse, Edoardo; Ficorella, Corrado; Cannita, K. | |
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer | 1-gen-2016 | Irelli, Azzurra; Cocciolone, Valentina; Cannita, Katia; Zugaro, Luigi; DI STASO, Mario; Lanfiuti Baldi, Paola; Paradisi, Stefania; Sidoni, Tina; Ricevuto, Enrico; Ficorella, Corrado |